FHKAX | FHKIX | FHKAX / FHKIX | |
Total Expense Ratio | 1.18 | 0.90 | 131% |
Annual Report Gross Expense Ratio | 1.18 | 0.90 | 131% |
Fund Existence | 17 years | 17 years | - |
Gain YTD | 11.105 | 11.249 | 99% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.15B | 1.15B | 100% |
Annual Yield % from dividends | 1.16 | 1.37 | 85% |
Returns for 1 year | 17.23 | 17.54 | 98% |
Returns for 3 years | 27.70 | 28.84 | 96% |
Returns for 5 years | 5.70 | 7.32 | 78% |
Returns for 10 years | 20.09 | 21.99 | 91% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EIHSX | 13.47 | -0.14 | -1.03% |
Eaton Vance Worldwide Health Sci I | |||
AGVDX | 25.32 | -0.32 | -1.25% |
American Funds Global Insight C | |||
CIVAX | 19.17 | -0.25 | -1.29% |
American Funds International Vntg 529-A | |||
HSLVX | 44.68 | -0.74 | -1.63% |
Hartford Small Cap Growth R6 | |||
SEKRX | 20.03 | -0.39 | -1.91% |
DWS Emerging Markets Equity R6 |